Endocrinology & Diabetes

Welcome

Endocrinology Conference invites worldwide global audience and presenters to participate at 3rd World Congress on Endocrinology & Diabetes which is to be held in Rome, Italy during June 13-14, 2024. Special interest and theme of the conference is “Harmony in Hormones: Navigating Diabetes and Endocrine Health”

The focus of the 2024 Diabetes Conference ,which emphasizes the most recent developments in the prevention, diagnosis, and management of a variety of metabolic disorders that may be caused by complications from diabetes and endocrinology. The conference also offers robust discussions on techniques and strategies for managing metabolic disorders and exploring new concepts and ideas for their treatment.

About conference

The “3rd World Congress on Endocrinology & Diabetes”, which is scheduled for “June 13-14, 2024” to address recent developments and transformations in Diabetes research and development, is the conference series' most eagerly awaited physical event. Two days of scientific keynote presentations, special sessions, poster presentations, networking, and discussions will be covered throughout this conference.

Endocrinology Conference is pleased to invite you to this physical Endocrinology Congress 2024 event.

With the help of another 1000 scientific societies, Conference Series LLC organizes 300+ conferences, 500+ workshops, and 200+ symposiums on general practice, pharmaceuticals, healthcare, cardiac diagnosis workshops, cardiology conferences, heart meetings, and science and technology each year in the United States, Europe generally, Asia, the Middle East, Australia, and the United Kingdom. publishes 500 open-access journals with editorial boards made up of more than 30000 well-known celebrities and world-class academics.

Tracks

Track 1: Diabetes and Sepsis

Track 2: Diabetes and Management

Track 3: Diabetes Retinopathy

Track 4: Cardiovascular and Diabetes Disorder

Track 5: Ophthalmology for Diabetes

Track 6: Diabetic Nephropathy

Track 7: Advanced Diabetes prevention and treatment

Track 8: Pre-Diabetes

Track 9: Weight loss and diet

Track 10: Genetics and Gene Regulation

Track 11: Diabetes and Covid-19

Track 12: Diagnosis and Treatment of Diabetes

Track 13: Diabetes Natural and Herbal Treatments

Track 14: Forms of Diabetes and their complications

Track 15: Diabetes and Metabolism

Track 16:  Diabetes in Pets

Track 17: Gestational Diabetes

Track 18: Stem Cell Therapy

Track 19: Latent Autoimmune Diabetes of Adults

Track 20: Thyroid condition

Benefits of Participation

• Get fresh knowledge about their area of specialization from the meeting's speakers through conversation, presentations and abstracts.
• Have face-to-face meetings with authors, presenters, and specialists to discuss novel concepts.
• Continuing education units.
• This might mark a turning point in their professional lives.
• Maintain and enhance your sense of self.
• Disseminate your research findings to investors and specialists throughout the world. Through introductions, governance conversations, panel discussions, and workshops, we explore each issue in its entirety, from large-scale global concerns to techniques to strategic problems.
• Participants will increase the accessibility of guides to a hub of leaders and consultants, as well as broaden perception through system evaluation and management at conferences.

For abstract submission

For registration

Target Audience

• Endocrinologists
• Diabetologist
• General Practitioners
• Nurses specializing in diabetes care
• Dietitians and nutritionists
• Professors and researchers from academic institutions with a focus on diabetes studies
• Pediatrist
• Professionals involved in developing diabetes medications and devices
• Representatives from pharmaceutical and medical device companies
• Diabetes educators
• Trainers involved in diabetes prevention and management programs
• Health department officials
• Representatives from relevant government agencies involved in healthcare and public health policies related to diabetes

Market Analysis

Endocrinology drugs market is poised to grow by over 6% during the forecast period. The report on endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The Endocrine market in Italy is estimated to reach more than 7% between 2022 and 2027. \Diabetes will affect around 9.9% of the Austria population by 2023. Unhealthy, a poor diet, and a physical inactivity all are included to rise a newly diagnosed Type 1 and Type 2 diabetes cases. 

This study identifies the research in novel dosage formulations and drug delivery systems as one of the prime reasons driving the endocrinology drugs market growth during the next few years.

The report on endocrinology drugs market covers the following areas:

Endocrinology drugs market sizing

Endocrinology drugs market forecast

Endocrinology drugs market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Endocrinology drugs market vendors that include Acerus Pharmaceuticals Corp., Beta Cell NV, Eli Lilly and Co., GlaxoSmithKline Plc, Ipsen Pharma SA, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., and Sanofi SA.

The report contains a comprehensive market and vendor landscape in addition to an analysis the vendors of key.

Past Conference

Endocrinology Congress-2023 report

Lexis Conference hosted the event “2nd world congress Endocrinology and diabetes” in March 13-14, 2022 held in Austria during October 18-19, 2023. The conferences were organized with a focus on the themes “Recent Advancements and Developments in Diabetes and Endocrinology.” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering. For more details